EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Short-term effect of sedation on kidney function markers in cats with chronic kidney disease

Zhan Hong Chew iD, Joanna D White

American Journal of Veterinary Research · 2026

DOI: 10.2460/ajvr.26.03.0088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Zhan Hong Chew und 1 weiteren Autor:innen. Beteiligte Einrichtung: Small Animal Specialist Hospital, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cat Diseases, Hypnotics and Sedatives, Glomerular Filtration Rate. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the short-term effect of sedation on GFR markers in cats with chronic kidney disease (CKD).

Methods

This was a prospective observational study involving client-owned cats with CKD undergoing abdominal sonography. Each cat received 50 mg oral gabapentin, 0.3 mg/kg butorphanol, and 0.3 mg/kg midazolam IM followed by 1 mg/kg alfaxalone IV to effect. Presedation blood tests included hematology and biochemistry. A second blood test for GFR markers (symmetric dimethylarginine [SDMA] and creatinine) was collected at the point of maximum sedation (20 cats) or 2 hours after sedation (12 cats).

Results

20 cats had presedation SDMA and creatinine concentrations of 19 µg/dL median (IQR, 15 to 24.5) and 200 µmol/L median (IQR, 147.5 to 260), respectively. These were not significantly different from samples from the point of maximal sedation (SDMA: median, 19 µg/dL; quantile [Q]-1 to Q3, 15 to 24.5; P = .31; creatinine: median, 200 µmol/L; IQR, 147.5 to 255; P = .71). Twelve cats had presedation SDMA and creatinine concentrations of 22 µg/dL median (IQR, 19.5 to 24.5) and 210 µmol/L median (IQR, 165 to 260), respectively. These were not significantly different from samples obtained 2 hours after sedation (SDMA: median, 25 µg/dL; IQR, 20 to 26; P = .51; creatinine: median, 200 µmol/L; Q1 to Q3, 175 to 280; P = .06). The only adverse effect was prolonged sedation in some cats.

Conclusions

Sedation with gabapentin, butorphanol, midazolam, and alfaxalone was an effective protocol for cats with CKD undergoing noninvasive diagnostic procedures and was not associated with short-term changes in GFR markers. Clinical Relevance The sedation protocol described is safe and effective in cats with CKD undergoing routine procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicCat DiseasesHypnotics and SedativesGlomerular Filtration RateProcedural SedationAnimalsCatsFemaleMaleMidazolamCreatinineButorphanolProspective StudiesGabapentinPregnanedionesArginineBiomarkersgamma-Aminobutyric Acid

Stichwörter der Autor:innen

catschronic kidney diseaseglomerular filtration ratekidney functionsedation

Substanzen

Hypnotics and SedativesMidazolamCreatinineButorphanolGabapentinPregnanedionesalphaxaloneArgininesymmetric dimethylarginineBiomarkers

Autor:innen und Institutionen

  • Small Animal Specialist Hospital, Adelaide, SA, Australia.
  • Small Animal Specialist Hospital, North Ryde, NSW, Australia.

ORCID-Profile: Zhan Hong Chew

Zitieren

APA

Chew, Z. H., & White, J. D. (2026). Short-term effect of sedation on kidney function markers in cats with chronic kidney disease. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.26.03.0088

Vancouver

Chew ZH, White JD. Short-term effect of sedation on kidney function markers in cats with chronic kidney disease. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.26.03.0088

BibTeX
@article{Chew2026,
  author = {Chew, Zhan Hong and White, Joanna D},
  title = {Short-term effect of sedation on kidney function markers in cats with chronic kidney disease},
  journal = {American Journal of Veterinary Research},
  year = {2026},
  doi = {10.2460/ajvr.26.03.0088}
}
Kostenlos starten →